Hospital
Jefferson Health - Northeast
Jefferson Health - Northeast was paid $1.71M by Medicaid between Oct 2018 and Dec 2024, across 90 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoJEFFERSON HEALTH - NORTHEAST
LANGHORNE, PA 19047
LANGHORNE, PA 19047
33aNPI1205904885assigned 12/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.71M
24GClaims33,531
24DCodes billed90
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#94 of 154
Median peer was paid$2.82M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31 | $5K | |
| 2019 | 44 | $5K | |
| 2020 | 4,279 | $345K | |
| 2021 | 13,676 | $950K | |
| 2022 | 2,647 | $100K | |
| 2023 | 5,533 | $129K | |
| 2024incomplete | 7,321 | $172K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 2,389 | 2,280 | $417K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 2,184 | 2,081 | $392K |
| G0378 | Hospital observation service, per hour | 20% | 410 | 264 | $336K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 5.7% | 741 | 733 | $98K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.7% | 511 | 159 | $80K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.6% | 622 | 614 | $61K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 3.5% | 529 | 168 | $59K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.9% | 408 | 392 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 177 | 172 | $27K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 259 | 253 | $23K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.1% | 50 | 50 | $19K |
| 95811 | 1.0% | 38 | 38 | $18K |
78 more codes
| 36000 | <1% | 188 | $16K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 622 | $16K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 263 | $11K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 40 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 524 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,653 | $7K |
| 0001A | <1% | 148 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,407 | $5K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 133 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 784 | $4K |
| 94729 | <1% | 93 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 225 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 538 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 50 | $3K |
| 0002A | <1% | 48 | $3K | |
| 94726 | <1% | 78 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 14 | $2K |
| 94060 | <1% | 109 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,409 | $2K |
| 76536 | <1% | 26 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 271 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 195 | $1K |
| 85027 | <1% | 186 | $1K | |
| 85730 | <1% | 297 | $964.96 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 26 | $962.66 |
| 73630 | <1% | 82 | $906.26 | |
| 76770 | <1% | 13 | $796.52 | |
| 71045 | Radiologic examination, chest; single view | <1% | 298 | $757.60 |
| 84484 | <1% | 374 | $710.52 | |
| 72100 | <1% | 27 | $683.36 | |
| 0004A | <1% | 12 | $651.34 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 67 | $636.41 |
| 80076 | <1% | 349 | $570.75 | |
| 85610 | <1% | 318 | $563.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 106 | $497.15 |
| 76642 | <1% | 12 | $474.26 | |
| 73130 | <1% | 34 | $466.81 | |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $453.25 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 42 | $421.00 |
| 72110 | <1% | 13 | $401.51 | |
| 80053 | Comprehensive metabolic panel | <1% | 135 | $384.21 |
| 83690 | <1% | 328 | $344.76 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 12 | $334.61 |
| 72050 | <1% | 12 | $295.57 | |
| 83735 | <1% | 207 | $230.25 | |
| 81003 | <1% | 303 | $222.19 | |
| 86900 | <1% | 56 | $205.86 | |
| 81001 | <1% | 176 | $158.27 | |
| A9270 | Non-covered item or service | <1% | 2,818 | $154.54 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 77 | $144.00 |
| 73110 | <1% | 13 | $136.43 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 202 | $69.13 |
| 87088 | <1% | 26 | $49.06 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16 | $46.42 |
| J2704 | Injection, propofol, 10 mg | <1% | 670 | $40.71 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,828 | $30.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,488 | $23.12 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 898 | $18.70 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 339 | $15.89 |
| 36415 | Collection of venous blood by venipuncture | <1% | 86 | $15.86 |
| 82962 | <1% | 78 | $14.26 | |
| 84703 | <1% | 16 | $10.26 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 730 | $4.20 |
| J3490 | Unclassified drugs | <1% | 1,542 | $4.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 848 | $1.87 |
| 91300 | <1% | 26 | $0.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 285 | $0.00 |
| 96376 | 0% | 36 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 98 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 399 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 33 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 75 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 62 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 90 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 59 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 33 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 14 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGALUP, RICHARD (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Jefferson Health - Northeast | Philadelphia, PA | $14.48M |
| Jefferson Health - Northeast | Philadelphia, PA | $5.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.